Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dicloxacillin Drug-Drug Interaction Cocktail Study
NCT02983890Phase 1Completed
- Start
- Oct 2016
- Primary completion
- Apr 2017
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dicloxacillin in bacterial infection. Started Oct 2016; status: completed.
02
Drugs
dicloxacillin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02983890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02983890.